Molecularis

The company offers a wide range of in vitro toxicological studies on chemicals and pharmaceuticals, in accordance with OECD guidelines, such as the skin corrosion test (OECD 431), the skin irritation test (OECD 439), the serious eye damage test (OECD 491), and the bacterial reverse mutation test, also known as the AMES test (OECD 471).

It operates strictly according to Good Laboratory Practice (GLP) principles and aims to obtain GLP certification within the year.

The company also offers customized research projects to investigate the effect of a test substance on human cell lines or 3D skin models. These studies can be used to detect inflammatory reactions or cell death, possibly in combination with microbial communities (microbiome, depending on the area of application).

As an expert in microbiology, the company is able to conduct toxicological studies involving aerobic, microaerophilic, and strictly anaerobic bacteria, biofilm assays, as well as the determination of minimal inhibitory, bactericidal, and fungicidal concentrations (MIC, MBC, MFC), in accordance with CLSI guidelines.

It establishes bacterial co-cultures to perform microbiome studies and remains open to new scientific challenges.

The company gladly develops new methods and designs innovative projects.

It also offers quality control testing for cosmetic products, such as challenge testing, endotoxin detection, and microbiological purity assessment.